Despite its established benefits, palliative care (PC) is rarely utilized for hematopoietic stem cell transplant (HSCT) patients. We sought to examine transplant physicians' perceptions of PC. METHODS: We conducted a cross-sectional survey of transplant physicians recruited from the American-Society-for-Blood-and-Marrow-Transplantation. Using a 28-item questionnaire adapted from prior studies, we examined physicians' access to PC services, and perceptions of PC. We computed a composite score of physicians' attitudes about PC (mean = 16.9, SD = 3.37) and explored predictors of attitudes using a linear mixed model. RESULTS: 277/1005 (28%) of eligible physicians completed the questionnaire. The majority (76%) stated that they trust PC clinicians to care for their patients, but 40% felt that PC clinicians do not have enough understanding to counsel HSCT patients about their treatments. Most endorsed that when patients hear the term PC, they feel scared (82%) and anxious (76%). Nearly half (46%) reported that the service name 'palliative care' is a barrier to utilization. Female sex (β = 0.85, P = .024), having <10 years of clinical practice (β = 1.39, P = .004), and perceived quality of PC services (β = 0.60, P < .001) were all associated with a more positive attitude towards PC. Physicians with a higher sense of ownership over their patients' PC issues (β = -0.36, P < .001) were more likely to have a negative attitude towards PC. CONCLUSIONS: The majority of transplant physicians trust PC, but have substantial concerns about PC clinicians' knowledge about HSCT and patients' perception of the term 'palliative care'. Interventions are needed to promote collaboration, improve perceptions, and enhance integration of PC for HSCT recipients. Cancer 2018;124:4556-4566.
INTRODUCTION
Patients undergoing hematopoietic stem cell transplantation (HSCT) face life-threatening diagnoses and experience immense physical and psychological symptoms. Together, these factors contribute to substantial deterioration in their quality of life and mood during hospitalization for HSCT. [1] [2] [3] [4] [5] [6] [7] HSCT survivors also struggle with posttransplant complications, long-term quality-of-life impairments, and psychological consequences, which further exacerbate the morbidity of HSCT. [1] [2] [3] [4] 6, [8] [9] [10] [11] [12] [13] Ultimately, HSCT recipients face complex physical and psychological symptoms that negatively affect their quality of life throughout their difficult and unpredictable illness course. [1] [2] [3] [4] 6, [8] [9] [10] [11] [12] [13] Early integration of specialty palliative care (PC) concurrently with oncology care for patients with advanced cancer has been shown to improve a wide range of patient-reported outcomes, including symptom burden, quality of life, depression, coping, and illness understanding. [14] [15] [16] [17] [18] A recent randomized clinical trial also demonstrated that early PC integrated with standard transplant care improves patient-reported quality of life, symptom burden, and psychological outcomes both during the transplant hospitalization and up to 6 months after HSCT. 19, 20 Despite these benefits, PC services are rarely consulted for the care of patients undergoing HSCT. [21] [22] [23] Cultural barriers and misperceptions of PC likely contribute to the lack of collaboration between HSCT physicians and specialty PC services, but there are few empirical data to support these hypotheses. [21] [22] [23] [24] [25] To promote PC integration in HSCT, we must have a more comprehensive understanding of transplant physicians' perceptions of PC and their perceived barriers to PC utilization.
To improve our understanding of transplant physicians' perceptions and attitudes about PC, we conducted a cross-sectional survey focusing on barriers to PC utilization and perspectives on unmet PC needs in the HSCT Cancer December 1, 2018 population. We also explored potential predictors of physicians' attitudes toward PC. We hypothesized that clinical and demographic factors as well as physicians' sense of ownership over addressing PC issues would emerge as important predictors of physicians' attitudes about PC. These data provide a more comprehensive understanding of transplant physicians' perceptions of PC and their perceived barriers to its utilization and a means for integrating PC into future transplant practice.
MATERIALS AND METHODS

Study Procedures
This study was approved by the National Marrow Donor Program's institutional review board. We conducted a cross-sectional, Web-based survey of transplant physicians. Participants were recruited from the American Society for Blood and Marrow Transplantation (ASBMT) membership list between January and February 2017. Eligible participants were transplant physicians who were providing direct clinical care to HSCT patients in the United States. Participants were recruited via an e-mail invitation explaining the purpose of the study, which included a link encouraging them to participate through the SurveyGizmo platform (SurveyGizmo, Boulder, Colorado). SurveyGizmo is a secure, password-protected tool that has been used extensively for survey administration. A total of 5 follow-up email contacts were made with nonresponders, with e-mail reminders sent on the second, third, fifth, and sixth weeks from the initial invitation. Participants who completed the survey could choose to receive honoraria via a $50 gift card.
Study Measures
We used prior validated instruments that had been used in the broader oncology field, and we adapted them to develop an HSCT-appropriate survey instrument for physicians. [26] [27] [28] [29] [30] The HSCT survey focused on measuring the following domains: 1) demographics and clinical practice characteristics (14 items), 2) access to and quality of PC services (4 items), 3) physicians' attitudes toward PC (6 items), 4) physicians' sense of ownership over PC issues (4 items), 5) physicians' perceptions of patients' attitudes toward PC (16 items), 6) barriers to PC utilization (11 items), and 7) perceptions of unmet PC needs in HSCT (8 items). The questionnaire content was developed and reviewed by the Palliative and Supportive Care Task Force of the ASBMT, which consists of a multidisciplinary team of transplant physicians, PC clinicians, nurses, social workers, clergy, former patients, health services researchers, and survey development experts. This interdisciplinary team reviewed the content of the survey items to ensure their readability, interpretability, and applicability to the HSCT setting. Before the national launch of the survey, we conducted pilot testing with 6 transplant physicians to ensure the clarity of the content, and we refined survey items on the basis of their feedback. The survey is available for public use from the corresponding author of this article.
As per prior studies, 26 we generated a composite score for physicians' attitudes about PC with the 6 items measuring this domain from the HSCT survey. Each item within physicians' attitudes about PC was scored on a Likert scale. We then created a summated composite score of all 6 items, with higher scores indicating more positive PC perceptions (range, . Given the focus of this study on measuring physicians' attitudes about PC, we a priori defined this domain as the outcome of interest in our secondary analysis.
We also used a similar methodology to generate composite scores corresponding to other survey domains that were a priori defined as potential predictors for physicians' attitudes about PC. Importantly, items unique to each domain were used to generate composite scores for the following domains: 1) physicians' sense of ownership over addressing PC issues (with higher scores indicating a higher sense of ownership; range, 4-16), 2) the extent of collaboration with PC (with higher scores indicating more collaboration; range, 0-6), 3) the perceived quality of PC services (with higher scores indicating better quality; range, 0-10), and 4) perceptions of unmet PC needs in the HSCT population (with higher scores indicating greater unmet needs; range, 0-32).
Statistical Analysis
We performed statistical analyses with SPSS (version 19) and SAS Enterprise Guide (version 6.1). The primary aims of this study were descriptive in nature. We used descriptive statistics, including frequencies and percentages for categorical variables and means and standard deviations for continuous variables, to examine participants' responses to survey items.
We used a linear mixed model adjusted for random effects of the transplant center to examine predictors of transplant physicians' attitudes about PC (the main outcome of interest). We included predictors that were defined a priori by the research team, including sex, race, years of clinical practice, importance of spirituality in clinical practice, time dedicated to clinical responsibilities, number of transplants performed at the HSCT center, prior training in PC (categorized as no training, continuing medical education [CME] courses and educational lectures, or rotation and/or 6 months or more of
Cancer December 1, 2018 formal training ± CME courses), extent of prior collaboration with PC, perceived quality of PC services, barriers to PC utilization, physicians' sense of ownership over PC issues, physicians' perceived expertise in managing patients' PC needs, and perceptions of the unmet PC needs in HSCT. We assessed for collinearity between all predictors included in the model with Pearson correlation coefficients, and we found positive collinearity between the perceived quality of PC services and the extent of collaboration with PC (r = 0.59, P < .001). Hence, we removed the extent of collaboration with PC from the final model. We considered a P value < .05 to be statistically significant.
RESULTS
Participant Characteristics
Of the 1005 eligible transplant physicians, 277 (28%) completed the survey (Table 1) . Most physicians were white (194 of 277 or 70%), not Hispanic or Latino (255 of 277 or 92%), and male (179 of 277 or 65%). All major regions of the United States were represented (Table 1) . Most physicians (179 of 277 or 65%) provided care to adult HSCT patients. Overall, 36% (101 of 277) had less than 10 years, 29% (80 of 277) had 10 to 20 years, and 35% (96 of 277) had more than 20 years of clinical practice. With respect to PC training, 46% (128 of 277) attended CME courses and lectures, 37% (102 of 277) had no PC training, 29% (81 of 277) reported attending a PC rotation during their residency or fellowship, and only 1% (4 of 277) had 6 months or more of formal PC training. We do not have data on nonresponders or all transplant physicians to compare their characteristics with those of the survey responders.
Access and Quality of PC Services
Physicians reported collaborating more often with PC services for inpatient care (118 of 277 or 43%) than outpatient care (57 of 277 or 21%). The quality of inpatient and outpatient PC services was considered excellent by 45% (124 of 277) and 30% (82 of 277) of physicians, respectively. When it came to ownership over PC issues, most physicians (245 of 277 or 88%) stated that a hematologist-oncologist should have expertise in the management of physical symptoms of hematologic diseases, and 84% (233 of 277) felt that a hematologist-oncologist should coordinate the care of patients across all stages of disease, including the end of life. When asked if a hematologist-oncologist would be the best person to provide PC for patients with hematologic disease, 16% (45 of 277) agreed with the statement, 38% (104 of 277) were neutral, and 46% (128 of 277) disagreed. Fig. 1 depicts physicians' attitudes about PC. The majority of physicians (193 of 277 or 70%) agreed that all patients with advanced hematologic diseases should receive PC, even if they are receiving active therapy. Although the majority (210 of 277 or 76%) stated that they trusted PC clinicians to care for their patients, 40% (110 of 277) endorsed that PC clinicians did not have enough understanding about hematology/oncology to counsel HSCT recipients regarding their treatments.
Perceptions and Attitudes About PC
Most physicians expressed concerns about how patients perceive PC (Fig. 2) . For example, most reported that when patients hear the term palliative care, they feel scared (227 of 277 or 82%), anxious (210 of 277 or 76%), and stressed (199 of 277 or 72%; Fig. 2A) . Moreover, if a PC referral is suggested, 65% of physicians (180 of 277) endorsed that patients may think nothing more can be done for their disease, and 51% (142 of 277) agreed that patients may think that they will lose contact with their current hematology-oncology care team once the PC team is involved (Fig. 2B) .
Perceived Barriers to PC Utilization
Nearly half of transplant physicians (127 of 277 or 46%) perceived the service name palliative care as a barrier to referral, and 66% (184 of 277) endorsed that it decreases hope in patients and families (Fig. 3A) . In contrast, transplant physicians felt more positively about the term supportive care (Fig. 3B ). Only 8% (22 of 277) perceived the service name supportive care as a barrier for them to refer patients, and just 11% (31 of 277) felt that it decreases hope in patients and families (Fig. 3B) .
Transplant physicians endorsed the following additional barriers to PC utilization: 1) patients' discomfort with discussing end-of-life care issues (222 of 277 or 80%), 2) families' discomfort with discussing end-of-life care issues (229 of 277 or 83%), 3) health care professionals' discomfort with death (168 of 277 or 61%), 4) a lack of clinical PC knowledge by HSCT physicians (167 of 277 or 60%), and 5) cultural factors influencing end-oflife care (232 of 277 or 84%). (18) 39 (14) 26 (9) 20 (7) 12 (4) Cancer December 1, 2018 or 63%), 5) preparing for future medical care (181 of 277 or 65%), and 6) supporting patients' families and friends (192 of 277 or 69%; Fig. 4 ).
Predictors of Transplant Physicians' Attitudes Toward PC
We identified several predictors of a more positive attitude toward PC, including female sex (β = 0.85, standard error [SE] = 0.38, P = .024), less than 10 years of clinical practice (β = 1.39, SE = 0.48, P =.004), and the perceived quality of PC services (β = 0.60, SE = 0.08, P < .001; Table 2 ). To the contrary, physicians who perceived the name palliative care as a barrier to utilization (β = -0.12, SE = 0.06, P = .061) and those with a higher sense of ownership over PC issues (β = -0.36, SE = 0.08, P < .001) were more likely to have a negative attitude toward PC.
DISCUSSION
To our knowledge, this is the first study to comprehensively examine transplant physicians' attitudes and perceptions about PC. Despite immense PC needs being reported for HSCT patients, only a minority of transplant physicians reported collaborating frequently with PC services. Notably, transplant physicians have a strong sense of ownership over addressing the palliative and end-of-life care needs of their patients and families. Although the majority of physicians reported trusting PC, they also expressed substantial concerns about PC clinicians' knowledge about HSCT. Most were also concerned about patients' perceptions of and emotional reactions to PC and identified these reactions as barriers to PC utilization. However, we also found that certain physician traits were associated with more positive attitudes toward PC, including a shorter duration of time in practice, which likely equates to having trained in an era in which PC involvement has been normalized as an increasingly standard part of cancer care. Similarly, we found that more positive attitudes about PC were associated with prior use of PC services, such that more exposure may translate to greater comfort and confidence Abbreviation: CME, continuing medical education. a Participants could choose multiple answers to these questions.
b All participants who chose other board certification also reported having board certification in hematology and/or oncology.
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in the value and acceptability of PC services in HSCT. These data underscore the need for interventions to promote education as well as collaboration between PC and HSCT services to help to overcome the substantial barriers to PC integration into the care of this vulnerable population to address its many unmet PC needs. Although the majority of transplant physicians reported a positive attitude toward PC, a substantial minority still questioned the involvement of PC clinicians in the care of HSCT recipients. Importantly, 40% of respondents agreed that PC clinicians did not have enough understanding of hematology-oncology to counsel HSCT patients regarding their treatments. Despite a recent randomized clinical trial demonstrating substantial benefits of early PC integration in HSCT, 19, 20 many transplant physicians remain unconvinced regarding the 
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potential role of PC expertise in addressing the needs of HSCT recipients. These findings are even more striking when they are compared with a prior survey of medical oncologists caring for patients with solid tumors, which demonstrated that more than 90% of these physicians agreed that all patients with advanced cancer should receive PC, even if they are receiving active antitumor therapy. 26 Transplant physicians' attitudes may in part reflect a lower rate of current collaboration with both inpatient and outpatient PC or a belief that PC clinicians do not have an adequate understanding of the different therapeutic options for patients with hematologic conditions. Nonetheless, these findings highlight the need to develop strategies to promote integration and enhance awareness of the potential role that PC can play in caring for patients undergoing HSCT and their families. Most transplant physicians expressed substantial concerns regarding how patients perceive PC. In fact, most physicians thought that patients would have a negative emotional reaction to PC, associating a PC referral with dying, thinking less positively about the future, or feeling abandoned by the transplant team. In contrast, most physicians endorsed that discussing death and dying and preparing for the future are important unmet PC needs in this population. Interestingly, evidence suggests that most laypersons do not know what PC is and do not inherently have positive or negative attitudes toward it. 31,32 Thus, patients' and families' perceptions of PC are most likely influenced by how it is presented to them by their medical team. Because many clinicians have negative perceptions about PC, it may be that a primary driver of patients' perceptions is the difficulty that clinicians have in explaining what PC is and introducing it as an important and integrated aspect of HSCT care. These findings underscore the critical need to enhance education about how to best discuss PC referrals with patients and how to present its role in enhancing the quality of life and care for patients throughout the course of their illness, regardless of their prognosis.
We also identified multiple perceived barriers to PC utilization, including patients', families', and health care professionals' discomfort with discussing end-of-life care issues, lack of knowledge about PC, and cultural factors. Furthermore, most physicians reported that the service name palliative care is a barrier for referral, and they preferred the term supportive care, as has been shown in other studies. 27, 33 However, transplant physicians' discomfort with the term palliative care surpasses what has been previously reported among oncologists caring for patients with solid tumors. 27 These data are important for consideration in the PC community in discussing whether changing the service name may affect physicians' perceptions of PC and their referral patterns. These barriers also highlight the common misconception equating PC with end-of-life care or hospice care. With mounting evidence supporting the benefit of early PC for all patients with Cancer December 1, 2018 serious illness, [14] [15] [16] [17] [18] [19] [20] there is a unique opportunity to promote PC involvement early in the course of illness and to overcome these misconceptions.
Our study has several important limitations. First, it is a cross-sectional survey of transplant physicians with a response rate of 28%; this potentially limits the generalizability of our findings. Although this response rate may seem low, it is better than what is commonly seen in contemporary electronic survey studies. 26, 27, 34 Thus, our conclusions must be tempered by the selection bias of survey respondents versus nonrespondents. However, our findings suggest that transplant physicians with more favorable perceptions of PC were more likely to complete this survey. As such, our findings likely underestimate the negative perceptions and attitudes about PC in the transplant community. Regardless of this bias, our findings are highly relevant for transplant and PC practices in the United States. Second, we did not capture the transplant centers of the study responders, and this limited our ability to examine any interdependence of survey responses based on transplant practice. Third, we limited this survey to transplant physicians, and thus we are unable to comment on the perception of PC by other transplant clinicians and advanced practice clinicians. Finally, the current study tested hypotheses concerning physicians' philosophies and practice plans. Patient attitudes are an equally important area of research and will be the subject of future studies by the ASBMT Palliative and Supportive Care Task Force.
In conclusion, our study demonstrates that the majority of transplant physicians hold positive attitudes about PC and trust PC clinicians. However, a substantial minority express concerns about PC expertise in caring for transplant patients. Importantly, most physicians worry that patients have a negative emotional and cognitive reaction to PC, and this is a major perceived barrier to PC utilization. Future efforts to promote early PC integration in HSCT will be critical for enhancing collaboration and bidirectional education and for overcoming the common misconceptions equating PC with end-of-life care and hospice care.
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The main outcome of interest in this predictive model is physicians' attitudes about palliative care as measured by a composite score, with higher values indicating more positive attitudes toward palliative care. A positive coefficient of estimate indicates a positive attitude about palliative care. For example, compared with physicians with more than 20 years of clinical practice, those physicians who had practiced less than 10 years had better attitudes about palliative care (1.39 points higher; P = .004). On the hand, a negative coefficient indicates a lower score and a more negative attitude toward palliative care. The majority of transplant physicians trust palliative care but have substantial concerns about palliative care clinicians' knowledge about hematopoietic stem cell transplantation and patients' perceptions of the term palliative care. Interventions are needed to promote collaboration, improve perceptions, and enhance the integration of palliative care for recipients of hematopoietic stem cell transplantation.
